These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8869767)

  • 1. Serotonin syndrome complicating migraine pharmacotherapy.
    Mathew NT; Tietjen GE; Lucker C
    Cephalalgia; 1996 Aug; 16(5):323-7. PubMed ID: 8869767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The problems of migraine headache treatment].
    Vilionskis A; Vaitkus A
    Medicina (Kaunas); 2002; 38(7):679-84. PubMed ID: 12474651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical approaches to migraine management.
    Diamond S; Wenzel R
    CNS Drugs; 2002; 16(6):385-403. PubMed ID: 12027785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged marijuana-like dysphoria after subcutaneous sumatriptan.
    Bakshi R; Yan-Go FL
    Ann Pharmacother; 1996 Jun; 30(6):683. PubMed ID: 8792959
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin 1D (5-HT1D) agonists and other agents in acute migraine.
    Mathew NT
    Neurol Clin; 1997 Feb; 15(1):61-83. PubMed ID: 9058397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic advances in migraine.
    Solomon GD
    J Clin Pharmacol; 1993 Mar; 33(3):200-9. PubMed ID: 8385160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptans to the rescue: effective therapy for migraine headaches in the workplace.
    Bartleson JD
    Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229
    [No Abstract]   [Full Text] [Related]  

  • 8. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer intranasal migraine medications.
    Logemann CD; Rankin LM
    Am Fam Physician; 2000 Jan; 61(1):180-6. PubMed ID: 10643958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serotonin syndrome as a result of concomitant use of paroxetine and sumatriptan].
    Hendrix Y; van Zagten MS
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):888-90. PubMed ID: 15868995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasospasm-induced myocardial infarction with sumatriptan.
    Mueller L; Gallagher RM; Ciervo CA
    Headache; 1996 May; 36(5):329-31. PubMed ID: 8682677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study.
    Carpay HA; Matthijsse P; Steinbuch M; Mulder PG
    Cephalalgia; 1997 Aug; 17(5):591-5. PubMed ID: 9251875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
    Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO
    Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 16. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies.
    Winner P; Mannix LK; Putnam DG; McNeal S; Kwong J; O'Quinn S; Richardson MS
    Mayo Clin Proc; 2003 Oct; 78(10):1214-22. PubMed ID: 14531480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptans and migraine.
    Bateman DN
    Lancet; 2000 Mar; 355(9207):860-1. PubMed ID: 10752697
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of sumatriptan: clinical trials and postmarketing experience.
    Allen C; Dayno J
    Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.